Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 16;17(1):54.
doi: 10.1186/s13023-022-02216-w.

Is it possible to implement a rare disease case-finding tool in primary care? A UK-based pilot study

Affiliations
Review

Is it possible to implement a rare disease case-finding tool in primary care? A UK-based pilot study

Orlando Buendia et al. Orphanet J Rare Dis. .

Abstract

Introduction: This study implemented MendelScan, a primary care rare disease case-finding tool, into a UK National Health Service population. Rare disease diagnosis is challenging due to disease complexity and low physician awareness. The 2021 UK Rare Diseases Framework highlights as a key priority the need for faster diagnosis to improve clinical outcomes.

Methods and results: A UK primary care locality with 68,705 patients was examined. MendelScan encodes diagnostic/screening criteria for multiple rare diseases, mapping clinical terms to appropriate SNOMED CT codes (UK primary care standardised clinical terminology) to create digital algorithms. These algorithms were applied to a pseudo-anonymised structured data extract of the electronic health records (EHR) in this locality to "flag" at-risk patients who may require further evaluation. All flagged patients then underwent internal clinical review (a doctor reviewing each EHR flagged by the algorithm, removing all cases with a clear diagnosis/diagnoses that explains the clinical features that led to the patient being flagged); for those that passed this review, a report was returned to their GP. 55 of 76 disease criteria flagged at least one patient. 227 (0.33%) of the total 68,705 of EHR were flagged; 18 EHR were already diagnosed with the disease (the highlighted EHR had a diagnostic code for the same RD it was screened for, e.g. Behcet's disease algorithm identifying an EHR with a SNOMED CT code Behcet's disease). 75/227 (33%) EHR passed our internal review. Thirty-six reports were returned to the GP. Feedback was available for 28/36 of the reports sent. GP categorised nine reports as "Reasonable possible diagnosis" (advance for investigation), six reports as "diagnosis has already been excluded", ten reports as "patient has a clear alternative aetiology", and three reports as "Other" (patient left study locality, unable to re-identify accurately). All the 9 cases considered as "reasonable possible diagnosis" had further evaluation.

Conclusions: This pilot demonstrates that implementing such a tool is feasible at a population level. The case-finding tool identified credible cases which were subsequently referred for further investigation. Future work includes performance-based validation studies of diagnostic algorithms and the scalability of the tool.

Keywords: Database analysis; Electronic health records; Primary care; Rare disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
MendelScan data flow and systems integration
Fig. 2
Fig. 2
Overview RD case-finding digital tool “MendelScan” implementation steps (Methods)
Fig. 3
Fig. 3
Internal review process methods
Fig. 4
Fig. 4
Feedback flowchart
Fig. 5
Fig. 5
Results overview of RD “MendelScan” implementation steps

References

    1. Somanadhan S, Nicholson E, Dorris E, Brinkley A, Kennan A, Treacy E, Atif A, Ennis S, McGrath V, Mitchell D, O'Sullivan G, Power J, Lawlor A, Harkin P, Lynch SA, Watt P, Daly A, Donnelly S, Kroll T. Rare disease research partnership (RAinDRoP): a collaborative approach to identify research priorities for rare diseases in Ireland. HRB Open Res. 2020;11(3):13. doi: 10.12688/hrbopenres.13017.2.PMID:33299965;PMCID:PMC7702160. - DOI - PMC - PubMed
    1. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y, Rath A. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165–173. doi: 10.1038/s41431-019-0508-0. - DOI - PMC - PubMed
    1. Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, Hughes DA, International Society for Pharmacoeconomics and Outcomes Research Rare Disease Special Interest Group. Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18(6):906–14. 10.1016/j.jval.2015.05.008. - PubMed
    1. Moliner AM, Waligora J. The European Union policy in the field of rare diseases. Adv Exp Med Biol. 2017;1031:561–587. doi: 10.1007/978-3-319-67144-4_30. - DOI - PubMed
    1. The UK Rare Diseases Framework [Internet]. GOV.UK. 2021 [cited 2021 May 18]. https://www.gov.uk/government/publications/uk-rare-diseases-framework/th....

Publication types